Chen, C.-H.; Chen, C.-C.; Wang, W.-B.; Lionel, V.; Liu, C.-C.; Huang, L.-M.; Wu, S.-C.
Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion Protein Elicits Systemic and Mucosal Immune Responses and Protection against Subcutaneous and Intravaginal Virus Challenges. Pharmaceutics 2022, 14, 1014.
https://doi.org/10.3390/pharmaceutics14051014
AMA Style
Chen C-H, Chen C-C, Wang W-B, Lionel V, Liu C-C, Huang L-M, Wu S-C.
Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion Protein Elicits Systemic and Mucosal Immune Responses and Protection against Subcutaneous and Intravaginal Virus Challenges. Pharmaceutics. 2022; 14(5):1014.
https://doi.org/10.3390/pharmaceutics14051014
Chicago/Turabian Style
Chen, Chi-Hsun, Chung-Chu Chen, Wei-Bo Wang, Vania Lionel, Chia-Chyi Liu, Li-Min Huang, and Suh-Chin Wu.
2022. "Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion Protein Elicits Systemic and Mucosal Immune Responses and Protection against Subcutaneous and Intravaginal Virus Challenges" Pharmaceutics 14, no. 5: 1014.
https://doi.org/10.3390/pharmaceutics14051014
APA Style
Chen, C.-H., Chen, C.-C., Wang, W.-B., Lionel, V., Liu, C.-C., Huang, L.-M., & Wu, S.-C.
(2022). Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion Protein Elicits Systemic and Mucosal Immune Responses and Protection against Subcutaneous and Intravaginal Virus Challenges. Pharmaceutics, 14(5), 1014.
https://doi.org/10.3390/pharmaceutics14051014
